{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:34:20Z","timestamp":1790732060131,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009864","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000}}],"reference-count":169,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009864.pub2","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T15:41:01Z","timestamp":1435765261000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Topical tacrolimus for atopic dermatitis"],"prefix":"10.1002","volume":"2016","author":[{"given":"Jade","family":"Cury Martins","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Department of Dermatology; Wagih Assad Abdalla 172 S\u00e3o Paulo S\u00e3o Paulo Brazil 05651-020"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Martins","sequence":"additional","affiliation":[{"name":"Belecara Premium Multispecialty Center; Department of Dermatology; 1427 Clarkview Road Suite 300B Baltimore Maryland USA 21210"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Aoki","sequence":"additional","affiliation":[{"name":"University of Sao Paulo Medical School Hospital das Clinicas; Department of Dermatology; Av. Dr. Eneas de Carvalho Aguir 255-sala 3016-ICHC S\u00e3o Paulo Brazil 05403-002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aecio FT","family":"Gois","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo; Brazilian Cochrane Centre; Rua Pedro de Toledo, 598 S\u00e3o Paulo S\u00e3o Paulo Brazil 04039-001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique A","family":"Ishii","sequence":"additional","affiliation":[{"name":"The University of Nottingham; c\/o Cochrane Skin Group; A103, King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina MK","family":"da Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino S\u00e3o Paulo S\u00e3o Paulo Brazil 04038-000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2230.2010.03948.x","article-title":"Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis","volume":"36","author":"Antiga","year":"2011","journal-title":"Clinical & Experimental Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1398-9995.2006.01269.x","article-title":"Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis","volume":"62","author":"Bieber","year":"2007","journal-title":"Allergy"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD009864.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0091-6749(98)70281-7","article-title":"A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group","volume":"102","author":"Boguniewicz","year":"1998","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2133.2006.07609.x","article-title":"The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study","volume":"156","author":"Caproni","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD009864.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-3038.2009.00895.x","article-title":"Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment","volume":"21","author":"Doss","year":"2010","journal-title":"Pediatric Allergy & Immunology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0006|cit6","first-page":"50","article-title":"The impact of tacrolimus ointment on health-related quality of life of Chinese adult and pediatric patients with atopic dermatitis (Chinese)","volume":"35","author":"Dou","year":"2006","journal-title":"Journal of Clinical Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaad.2005.06.013","article-title":"Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison","volume":"53","author":"Draelos","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630701287332","article-title":"Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis","volume":"18","author":"Fleischer","year":"2007","journal-title":"Journal of Dermatological Treatment"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009864.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1067\/mjd.2001.109810","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy","volume":"44","author":"Hanifin","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD009864.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety","volume":"44","author":"Soter","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1081-1206(10)60859-9","article-title":"Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics","volume":"98","author":"Hung","journal-title":"Annals of Allergy, Asthma, & Immunology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaad.2004.01.051","article-title":"A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis","volume":"51","author":"Kempers","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0013|cit13","first-page":"569","article-title":"Efficacy and Safety of FK506 (Tacrolimus) Ointment in Children with Atopic Dermatitis-Phase III Double-blinded Comparison with Vehicle Ointment","volume":"19","author":"Otsuki","year":"2003","journal-title":"Journal of Clinical Therapeutics & Medicines (Rinsho Iyaku)"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2222.2004.1907.x","article-title":"Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study","volume":"34","author":"Pacor","year":"2004","journal-title":"Clinical & Experimental Allergy"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD009864.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1067\/mjd.2001.109813","article-title":"A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients","volume":"44","author":"Paller","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD009864.pub2-BIB0016|cit16","first-page":"1153","article-title":"Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream","volume":"7","author":"Abramovits","year":"2008","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jaad.2004.12.038","article-title":"Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies","volume":"52","author":"Paller","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1067\/mai.2002.121832","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mai.2002.121831","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1365-2133.2004.05782.x","article-title":"0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial","volume":"150","author":"Reitamo","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2340\/00015555-0803","article-title":"One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial","volume":"90","author":"Mandelin","year":"2010","journal-title":"Acta Dermato-Venereologica"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1468-3083.2009.03485.x","article-title":"Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids","volume":"24","author":"Poole","year":"2010","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2133.2005.06592.x","article-title":"A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis","volume":"152","author":"Reitamo","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0024|cit24","first-page":"304","article-title":"Topical 0.03% tacrolimus ointment, 0.05% clobetasone butyrate cream alone and their combination in older children with atopic dermatitis - An open randomized comparative study","volume":"15","author":"Sikder Md","year":"2005","journal-title":"Journal of Pakistan Association of Dermatologists"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2230.2006.02313.x","article-title":"Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis","volume":"32","author":"Arkwright","year":"2007","journal-title":"Clinical & Experimental Dermatology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009864.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2005.04.061","article-title":"Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis","volume":"53","author":"Chapman","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ddg.12074","article-title":"Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis","volume":"11","author":"D\u00e4hnhardt-Pfeiffer","year":"2013","journal-title":"Journal Der Deutschen Dermatologischen Gesellschaft"},{"issue":"9","key":"10.1002\/14651858.CD009864.pub2-BIB0028|cit28","first-page":"545","article-title":"An Investigator-Blinded Evaluation of Fluocinonide 0.1% Cream in the Treatment of Atopic Dermatitis and Psoriasis Vulgaris","volume":"20","author":"Rosso","year":"2007","journal-title":"Cosmetic Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2133.2009.09143.x","article-title":"Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial","volume":"161","author":"Doss","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD009864.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1651-2227.2007.00363.x","article-title":"Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus","volume":"96","author":"Gradman","year":"2007","journal-title":"Acta Paediatrica"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00015550152573083","article-title":"Treatment of Lichenified Atopic Eczema with Tacrolimus Ointment","volume":"81","author":"Granlund","year":"2001","journal-title":"Acta Dermato-Venereologica"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0032|cit32","first-page":"357","article-title":"Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis","volume":"78","author":"Hebert","year":"2006","journal-title":"Cutis"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2133.2006.07707.x","article-title":"Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data","volume":"156","author":"Hjelmgren","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0034|cit34","first-page":"317","article-title":"Early Phase II Study of FK506 Ointment on Atopic Dermatitis","volume":"13","author":"Ishibashi","year":"1997","journal-title":"Rinsho Iyaku (Journal of Clinical Therapeutics and Medicines)"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/09546630310004324","article-title":"Safe treatment of head\/neck AD with tacrolimus ointment","volume":"14","author":"Kang","year":"2003","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2340\/00015555-0748","article-title":"Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids","volume":"90","author":"Kirsner","year":"2010","journal-title":"Acta Dermato-Venereologica"},{"issue":"10","key":"10.1002\/14651858.CD009864.pub2-BIB0037|cit37","first-page":"608","article-title":"Efficacy and Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis in Chinese Children","volume":"38","author":"Liu","year":"2005","journal-title":"Chinese Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD009864.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1610-0387.2008.06641.x","article-title":"A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis","volume":"6","author":"Neumann","year":"2008","journal-title":"Journal Der Deutschen Dermatologischen Gesellschaft"},{"issue":"10","key":"10.1002\/14651858.CD009864.pub2-BIB0039|cit39","first-page":"1145","article-title":"Pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis: A pilot study on patient preference","volume":"12","author":"Onumah","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0040|cit40","first-page":"84","article-title":"Efficacy of topical tacrolimus in atopic dermatitis","volume":"18","author":"Rahman","year":"2008","journal-title":"Journal of Pakistan Association of Dermatologists"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-4632.2009.03853.x","article-title":"The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis","volume":"48","author":"Reitamo","year":"2009","journal-title":"International Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD009864.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199709183371203","article-title":"A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group","volume":"337","author":"Ruzicka","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1542\/peds.2004-2638","article-title":"Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study","volume":"116","author":"Schachner","year":"2005","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5021\/ad.2012.24.2.144","article-title":"A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis","volume":"24","author":"Takeuchi","year":"2012","journal-title":"Annals of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0045|cit45","first-page":"161","article-title":"Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis","volume":"72","author":"Torok","year":"2003","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/09546630310020812","article-title":"A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea","volume":"15","author":"Won","year":"2004","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000100884","article-title":"Comparative effect of tacrolimus and betamethasone valerate on the passive sustainable hydration of the stratum corneum in atopic dermatitis","volume":"214","author":"Xhauflaire-Uhoda","year":"2007","journal-title":"Dermatology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD009864.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1067\/mjd.2001.109814","article-title":"The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis","volume":"44","author":"Drake","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0049|cit49","unstructured":"NCT00475605 APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis clinicaltrials.gov\/ct2\/show\/NCT00475605"},{"issue":"8","key":"10.1002\/14651858.CD009864.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2006.01153.x","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report","volume":"61","author":"Akdis","year":"2006","journal-title":"Allergy"},{"issue":"9","key":"10.1002\/14651858.CD009864.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00228-012-1255-0","article-title":"Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009","volume":"68","author":"Aldea","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0052|cit52","first-page":"747","article-title":"Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome","volume":"137","author":"Allen","year":"2001","journal-title":"Archives of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD009864.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/archderm.138.9.1259","article-title":"Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis","volume":"138","author":"Allen","year":"2002","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archderm.140.4.457","article-title":"Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment","volume":"140","author":"Antille","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5700622","article-title":"Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis","volume":"127","author":"Arellano","year":"2007","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaci.2009.02.028","article-title":"Lymphoma among patients with atopic dermatitis and\/or treated with topical immunosuppressants in the United Kingdom","volume":"123","author":"Arellano","year":"2009","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"7490","key":"10.1002\/14651858.CD009864.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.38376.439653.D3","article-title":"Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials","volume":"330","author":"Ashcroft","year":"2005","journal-title":"BMJ"},{"issue":"7490","key":"10.1002\/14651858.CD009864.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.38376.439653.D3","article-title":"Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials","volume":"330","author":"Ashcroft","year":"2005","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005500.pub2","article-title":"Topical pimecrolimus for eczema","author":"Ashcroft","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1465-9921-11-8","article-title":"Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One","volume":"11","author":"Asher","year":"2010","journal-title":"Respiratory Research"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005203.pub2","article-title":"Dietary exclusions for established atopic eczema","author":"Bath-Hextall","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD009864.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1067\/mjd.2001.109816","article-title":"Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis","volume":"44","author":"Bekersky","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2133.2003.05443.x","article-title":"Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption","volume":"149","author":"Bens","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaad.2006.01.054","article-title":"The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force","volume":"54","author":"Berger","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000091256","article-title":"Significantly elevated systemic levels after occlusive application of topical tacrolimus in atopic dermatitis","volume":"212","author":"Beyeler","year":"2006","journal-title":"Dermatology"},{"issue":"2 Suppl Mini-Pr","key":"10.1002\/14651858.CD009864.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1016\/j.jaci.2005.10.018","article-title":"Atopic Dermatitis","volume":"117","author":"Boguniewicz","year":"2006","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-0625.2009.01024.x","article-title":"Atopic eczema or atopiform dermatitis","volume":"19","author":"Bos","year":"2010","journal-title":"Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1525-1470.2008.00745.x","article-title":"The course of life of patients with childhood atopic dermatitis","volume":"26","author":"Brenninkmeijer","year":"2009 Jan-Feb","journal-title":"Pediatric Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00128071-200506020-00001","article-title":"Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis","volume":"6","author":"Breuer","year":"2005","journal-title":"American Journal of Clinical Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/000155501750376294","article-title":"Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study","volume":"81","author":"B\u00f6hme","year":"2001","journal-title":"Acta Dermato-Venereologica"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2133.2006.07538.x","article-title":"A systematic review of the safety of topical therapies for atopic dermatitis","volume":"156","author":"Callen","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2133.2005.06398.x","article-title":"Tacrolimus ointment-associated alcohol intolerance in infants receiving ethanol-containing medication","volume":"152","author":"Calza","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archdermatol.2012.377","article-title":"Induced lentiginosis with use of topical calcineurin inhibitors","volume":"148","author":"Castelo-Soccio","year":"2012","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1542\/peds.2004-0374","article-title":"Effects of atopic dermatitis on young American children and their families","volume":"114","author":"Chamlin","year":"2004","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archderm.136.6.763","article-title":"Outcome Measures of Disease Severity in Atopic Eczema","volume":"136","author":"Charman","year":"2000","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/09546630903401470","article-title":"Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials","volume":"21","author":"Chen","year":"2010","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0190-9622(03)02145-5","article-title":"Development of Kaposi's sarcoma in an AIDS patient after treatment with topical tacrolimus","volume":"50","author":"Cho","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1610-0387.2011.07791.x","article-title":"Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues","volume":"10","author":"Czarnecka-Operacz","year":"2012","journal-title":"Journal Der Deutschen Dermatologischen Gesellschaft"},{"issue":"8","key":"10.1002\/14651858.CD009864.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archderm.140.8.1014","article-title":"Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin","volume":"140","author":"Ehst","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdermsci.2009.02.002","article-title":"Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis","volume":"54","author":"El-Batawy","year":"2009","journal-title":"Journal of Dermatological Science"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD009864.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.sder.2012.07.006","article-title":"Understanding and managing atopic dermatitis in adult patients","volume":"31","author":"Ellis","year":"2012","journal-title":"Seminars in Cutaneous Medicine & Surgery"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1183\/09031936.01.17304360","article-title":"Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group","volume":"17","author":"Ellwood","year":"2001 Mar","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.clindermatol.2010.03.032","article-title":"Atopic dermatitis and nutrition","volume":"28","author":"Finch","year":"2010","journal-title":"Clinics in Dermatology"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0086|cit86","volume-title":"Fitzpatrick's Dermatology in General Medicine","volume":"1","author":"Wolff","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0087|cit87","first-page":"705","article-title":"Long-term study of FK506 (tacrolimus) ointment in patients with atopic dermatitis - analysis at time of completion of 2-year observation","volume":"17","author":"FK506 Ointment Study Group","year":"2001","journal-title":"Journal of Clinical Therapeutics and Medicines"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jaci.2005.04.006","article-title":"Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology","volume":"115","author":"Fonacier","year":"2005","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaad.2009.01.029","article-title":"Rosaceiform dermatitis associated with topical tacrolimus treatment","volume":"62","author":"Fujiwara","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1067\/mjd.2001.114739","article-title":"Tacrolimus ointment for thetreatment of steroid-induced rosacea: a preliminary report","volume":"44","author":"Goldman","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1590\/S0365-05962008000600003","article-title":"Evaluate of the efficacy and safety of tacrolimus ointment 0, 03% to treat atopic dermatitis in pediatric patients","volume":"83","author":"Gontijo","year":"2008","journal-title":"Anais Brasileiros De Dermatologia"},{"issue":"7650","key":"10.1002\/14651858.CD009864.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1002\/14651858.CD009864.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Dermato-Vereneologica"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","author":"Hanifin","year":"2001","journal-title":"Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0022-202X.2005.23644.x","article-title":"A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis","volume":"124","author":"Harper","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2222.2007.02679.x","article-title":"Eczema, atopy and allergen exposure in adults: a population-based study","volume":"37","author":"Harrop","year":"2007","journal-title":"Clinical & Experimental Allergy"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2133.2004.06280.x","article-title":"Does topical tacrolimus induce lentigines in children with atopic dermatitis? A report of three cases","volume":"152","author":"Hickey","year":"2005","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0098|cit98","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"12","key":"10.1002\/14651858.CD009864.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1345\/aph.1M278","article-title":"Association between exposure to topical tacrolimus or pimecrolimus and cancers","volume":"43","author":"Hui","year":"2009","journal-title":"Annals of Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000086739","article-title":"Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis","volume":"211","author":"Hultsch","year":"2005","journal-title":"Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jech.53.1.46","article-title":"Assessment of theSF-36 version 2 in the United Kingdom","volume":"53","author":"Jenkinson","year":"1999","journal-title":"Journal of Epidemiology & Community Health"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1054\/bjoc.2001.1931","article-title":"Non-melanoma skin cancers and glucocorticoid therapy","volume":"85","author":"Karagas","year":"2001","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1081-1206(10)61227-6","article-title":"Alcohol-induced rash caused by topical tacrolimus","volume":"95","author":"Knight","year":"2005","journal-title":"Annals of Allergy, Asthma, & Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0105|cit105","first-page":"200","article-title":"Immunodeficiency-associated lymphoproliferative disorders","volume":"12","author":"Knowles","year":"1999","journal-title":"Modern Pathology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009864.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.jaad.2005.04.063","article-title":"Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients","volume":"53","author":"Koo","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1365-2133.2004.06017.x","article-title":"Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis","volume":"150","author":"Kyll\u00f6nen","year":"2004","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008024","article-title":"Tacrolimus ointment-induced relapse of schizophrenia: a case report","volume":"10","author":"Lin","year":"2007","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009864.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1529-8019.2008.00198.x","article-title":"Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects","volume":"21","author":"Lotti","year":"2008","journal-title":"Dermatologic Therapy"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0111|cit111","first-page":"415","article-title":"Viewpoint of the German Dermatologic Society (DDG) concerning the decision of the American Food and Drug Administration (FDA) on the use of pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis (neurodermatitis)","volume":"3","author":"Luger","year":"2005","journal-title":"Journal Der Deutschen Dermatologischen Gesellschaft"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1468-3083.2010.03789.x","article-title":"Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate","volume":"25","author":"Luger","year":"2011","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2010.03.044","article-title":"Superantigens in dermatology","volume":"64","author":"Macias","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0114|cit114","first-page":"1","article-title":"Pimecrolimus and tacrolimus: the US FDA public health advisory","volume":"10","author":"Maddin","year":"2005","journal-title":"Skin Therapy Letter"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2011.01295.x","article-title":"Health-related quality of life in patients with atopic dermatitis","volume":"39","author":"Maksimovi\u0107","year":"2012","journal-title":"Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-4632.2011.05015.x","article-title":"Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study","volume":"51","author":"Mandelin","year":"2012","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000100879","article-title":"Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults","volume":"214","author":"Margolis","year":"2007","journal-title":"Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1525-1470.2010.01223.x","article-title":"The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis","volume":"27","author":"McCollum","year":"2010","journal-title":"Pediatric Dermatology"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0119|cit119","unstructured":"Medline Plus\u00ae Medical Dictionary http:\/\/www.merriam-webster.com\/medlineplus\/antibody"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0120|cit120","unstructured":"Medline Plus\u00ae Medical Dictionary http:\/\/www.merriam-webster.com\/medlineplus\/prick%20test"},{"issue":"12","key":"10.1002\/14651858.CD009864.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/archderm.140.12.1542-b","article-title":"Alcohol intolerance and facial flushing in patients treated with topical tacrolimus","volume":"140","author":"Milingou","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1346-8138.2010.01046.x","article-title":"Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor","volume":"38","author":"Mitamura","year":"2011","journal-title":"Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0733-8635(05)70005-X","article-title":"The benefits and risks of long-term PUVAphotochemotherapy","volume":"16","author":"Momtaz","year":"1998","journal-title":"Dermatologic Clinics"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/09546630510041088","article-title":"Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus","volume":"16","author":"Naylor","year":"2005","journal-title":"Journal of Dermatological Treatment"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2133.2005.06899.x","article-title":"Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?","volume":"153","author":"Ormerod","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD009864.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/archderm.139.9.1184","article-title":"The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis","volume":"139","author":"Patel","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00128071-200708040-00001","article-title":"Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians","volume":"8","author":"Patel","year":"2007","journal-title":"American Journal of Clinical Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/00015550510040923","article-title":"Systemic absorption of topical tacrolimus in Pyoderma gangrenosum","volume":"86","author":"Pitarch","year":"2006","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0130|cit130","first-page":"13","article-title":"Grading of the severity of atopic dermatits","volume":"144","author":"Rajka","year":"1989","journal-title":"Acta Dermato-Venereologica. Supplementum"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"e17520","DOI":"10.1371\/journal.pone.0017520","article-title":"Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985-2010","volume":"6","author":"Rehal","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.1998.00323.x","article-title":"Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial","volume":"111","author":"Reitamo","year":"1998","journal-title":"Journal of Investigative Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD009864.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archderm.136.8.999","article-title":"Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis.The European Tacrolimus OintmentStudy Group","volume":"136","author":"Reitamo","year":"2000","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0134|cit134","unstructured":"Reitamo S Rubins A Ho V Pharmacokinetics of topical tacrolimus in paediatric patients aged 3 to 24 months 15th Congress of the European Academy of Dermatology andVenereology, Rhodes, Greece 2006"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2340\/00015555-0282","article-title":"Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study","volume":"87","author":"Reitamo","year":"2007","journal-title":"Acta Dermato-Venereologica"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.2008.08747.x","article-title":"A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients","volume":"159","author":"Reitamo","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2340\/00015555-0167","article-title":"Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children","volume":"87","author":"Remitz","year":"2007","journal-title":"Acta Dermato-Venereologica"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1468-3083.2005.01315.x","article-title":"Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum","volume":"19","author":"Ring","year":"2005","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2013.07.049","article-title":"Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review","volume":"133","author":"Roekevisch","year":"2014","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2007.08177.x","article-title":"The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review","volume":"157","author":"Rustin","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-4632.2006.02956.x","article-title":"Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings","volume":"46","author":"Saif","year":"2007","journal-title":"International Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0142|cit142","first-page":"396","article-title":"Evaluation of the efficacy, safety and tolerability of Tacrolimus ointment in Indian patients of moderate to severe atopic dermatitis: a multicentric, open label, phase III study","volume":"69","author":"Saple","year":"2003","journal-title":"Indian Journal of Dermatology, Venereology & Leprology"},{"issue":"2","key":"10.1002\/14651858.CD009864.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.2010.10030.x","article-title":"Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials","volume":"164","author":"Schmitt","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0151-9638(06)70905-X","article-title":"Kaposi's sarcoma in an AIDS patient after application of tacrolimus (Protopic)","volume":"133","author":"Schmutz","year":"2006","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000209289","article-title":"Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma","volume":"219","author":"Schneeweiss","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2008.03.043","article-title":"A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis","volume":"59","author":"Schwarz","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-9-24","article-title":"CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults","volume":"9","author":"Segal","year":"2013","journal-title":"Allergy, Asthma, & Clinical Immunology : Official Journal of the Canadian Society of Allergy & Clinical Immunology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaad.2003.09.013","article-title":"Allergic contact dermatitis from tacrolimus","volume":"50","author":"Shaw","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40257-013-0020-1","article-title":"Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice","volume":"14","author":"Siegfried","year":"2013","journal-title":"American Journal of Clinical Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/all.12339","article-title":"Systemic therapy for atopic dermatitis","volume":"69","author":"Simon","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0151-9638(05)79260-7","article-title":"Important systemic absorption of topical tacrolimus during treatment of severe pemphigus vulgaris","volume":"132","author":"Skowron","year":"2005","journal-title":"Annales de Dermatologie et de Venereologie"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2458-4-51","article-title":"Allergic conditions and the risk of hematological malignancies in adults: a cohort study","volume":"4","author":"Soderberg","year":"2004","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1002\/14651858.CD009864.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/djh118","article-title":"Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study","volume":"96","author":"Sorensen","year":"2004","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1067\/mjd.2001.114576","article-title":"The risk of melanoma in association with long-term exposure to PUVA","volume":"44","author":"Stern","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009864.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/j.jaad.2005.04.064","article-title":"Pneumococcal seroconversion after vaccination in children with atopic dermatitis treated with tacrolimus ointment","volume":"53","author":"Stiehm","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6710","key":"10.1002\/14651858.CD009864.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.299.6710.1259","article-title":"Hay fever, hygiene, and household size","volume":"299","author":"Strachan","year":"1989","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD009864.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1185\/03007995.2011.582483","article-title":"A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis","volume":"27","author":"Svensson","year":"2011","journal-title":"Current Medical Research & Opinion"},{"issue":"3","key":"10.1002\/14651858.CD009864.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2133.2011.10363.x","article-title":"Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors","volume":"165","author":"Tennis","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000338693","article-title":"Tacrolimus-induced rosacea-like dermatitis: a clinical analysis of 16 cases associated with tacrolimus ointment application","volume":"224","author":"Teraki","year":"2012","journal-title":"Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD009864.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000088505","article-title":"Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hairless mouse epidermis","volume":"211","author":"Tran","year":"2005","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD009864.pub2-BIB0161|cit161","unstructured":"US Food Drug Administration (FDA) Pediatric Advisory Committee February 15th 2005. Briefing Information. Labeling Information and NDAs www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/2005-4089b2.htm"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0625.2007.00555.x","article-title":"Calcineurin inhibitors and rapamycin: cancer protection or promotion?","volume":"16","author":"Weischer","year":"2007","journal-title":"Experimental Dermatology"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD009864.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","article-title":"Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood","volume":"103","author":"Williams","year":"1999","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"7","key":"10.1002\/14651858.CD009864.pub2-BIB0164|cit164","first-page":"485","article-title":"Efficacy and safety of topically applied tacrolimus ointment in patients with moderate to severe atopic dermatitis","volume":"26","author":"Wong","year":"2003","journal-title":"Chang Gung Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD009864.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1525-1470.2007.00600.x","article-title":"Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients","volume":"25","author":"Yan","year":"2008","journal-title":"Pediatric Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD009864.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1346-8138.2012.01529.x","article-title":"Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis","volume":"39","author":"Yin","year":"2012","journal-title":"Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2340\/00015555-0878","article-title":"Labial melanotic macule after application of topical tacrolimus: two case reports","volume":"90","author":"Zattra","year":"2010","journal-title":"Acta Dermato-Venereologica"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD009864.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2133.1996.tb00704.x","article-title":"The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens","volume":"135","author":"Zonneveld","year":"1996","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD009864.pub2-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009864","article-title":"Topical tacrolimus for atopic dermatitis","author":"Cury Martins","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009864.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T20:11:40Z","timestamp":1717963900000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009864.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":169,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009864.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]}}}